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SURGICALTECHNIQUESTunneling of ventricular assist device outflow graft rostral to superior
vena cavaPrashant N. Mohite, MCh, Aron F. Popov, MD, Tarun K. Mittal, MD, and Andre R. Simon, MD, Harefield,
United KingdomA majority of patients supported with ventricular assist
devices (VADs) require further surgical interventions for
heart transplantation, removal of the device upon recovery,
or complications that involve re-sternotomy. Proper place-
ment of the outflow graft in relation to intrathoracic struc-
tures is a key element to avoid its injury during sternotomy.CLINICAL SUMMARY
A33-year-oldman diagnosedwith familial dilated cardio-
myopathy whose disease was being managed with medical
therapy was deteriorating clinically. He underwent assess-
ment for heart transplantation and was accepted on the wait-
ing list. Echocardiography showed severely dilated left and
right ventricles with poor systolic function, severe tricuspid
regurgitation, and a patent foramen ovale. In view of deteri-
orating renal and hepatic function despitemaximummedical
therapy including inotropic support, it was decided to im-
plant a ventricular assist device as a bridge to transplant.
At surgery, the patient was put on cardiopulmonary by-
pass (CPB) via aortic and bicaval cannulation. The opera-
tion was performed on a beating heart with the foramen
ovale being closed first, followed by the tricuspid annulo-
plasty using a 36 mm ring. The HeartWare ventricular assist
device (HeartWare International Inc, Framingham, Mass)
was implanted in a routine fashion. The connective tissue
rostral to the superior vena cava (SVC), caudal to the azygos
vein was dissected and the outflow graft was passed under
the SVC, in close proximity to the right pulmonary artery
(Figure 1). The length of the graft was adjusted and it was
anastomosed laterally to the ascending aorta. After addi-
tional de-airing, the HVAD was started with flows> 5 L/
minute. A computed tomography (CT) scan performed after
a week showed ideal positioning of the outflow graft situ-
ated beneath the SVC without kinking or compromising
the SVC caliber (Figure 2). The patient made rapid recovery
and was discharged after 3 weeks.From the Department of Cardiothoracic Transplantation & Mechanical Support,
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The disparity between donor hearts and potential recipi-
ents has formed a niche well filled by VADs.1,2 Continuous-
flow centrifugal pumps are newer-generation VADs being
used as a standard of care for end-stage heart failure.3,4
Conventionally, outflow graft of the left VAD spouts out
from the device motor, and travels along the right side of
the heart over the superior vena cava to terminate into the
ascending aorta. This brings the graft in close proximity
to the sternum. It is implied that all bridge-to-transplant pa-
tients who survive will undergo re-sternotomy at some
point. The proximity of the outflow graft to the sternum
poses a significant risk of lacerating the graft, possibly re-
sulting in catastrophic hemorrhage, exsanguinations, or ce-
rebral damage.
We innovated an approach that passes the outflowgraft un-
der the SVC before anastomosing it to the ascending aorta.
This modification avoids the graft coming in contact with
the sternum. The entry angle into the convex aspect of the lat-
eral ascending aorta is ideal and the chances of kinking the
graft after closure of the chest are minimized because graft
position remains stable under the SVC. The theoretical pos-
sibility of external compression of SVC by the outflow graft
cannot be ruled out. However, the graft nests in the space be-
tween the higher pressure pulmonary artery, lower end of theFIGURE 1. Outflow graft passing under the superior vena cava and anas-
tomosing to ascending aorta. SVC, Superior vena cava; RA, right atrium;
Ao, aorta.
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FIGURE 2. Computed tomography scan showing passage of outflow graft under the superior vena cava. SVC, Superior vena cava; OG, outflow graft;
Ao, aorta; RA, right atrium; RPA, right pulmonary artery.
Surgical TechniquesSVC, and roof of the left atrium, rendering compression of
the SVC unlikely. As expected, we did not encounter SVC
syndrome and the CT scan did not show any compression.
At the time of VAD explant due to recovery or heart trans-
plant, we propose to either remove the whole graft or leave
a few millimeters of length behind the SVC if the adhesions
prohibit to its removal, thereby avoiding dissection and in-
jury to adjoining structures like the right pulmonary artery,
azygous vein, and SVC. Because the graft runs inside the
pericardium, the phrenic nerve remains protected. The tech-
nique is simple, easy, and reproducible.From the Division of Cardiac Surgery, Department of Surgery, Johns Hopkins Hospi-
tal, Baltimore, Md.
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2009;138:1425-32.e1-3.Use of cryopreserved saphenous vein grafts in congenital
heart surgeryArman Kilic, MD, Duke E. Cameron, MD, and Luca A. Vricella, MD, Baltimore, MdThe use of saphenous vein grafts (SVGs) in congenital heart
surgery was reported as early as 1984.1 SVGs have several
advantages, including a low incidence of thrombosis and
infection and superior handling characteristics and hemo-
stasis, with acceptable patency rates. A potential hemody-
namic benefit of a competent valve also exists in cases in
which SVGs are used as right ventricle to pulmonary artery
(RV-PA) conduits.2 We report our experience with cryopre-
served SVGs as RV-PA conduits or modified Blalock-
Taussig shunts (MBTSs) in neonates and infants.gery c December 2012
